1.Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin.2018 Nov;68(6): 394–424.
2.Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, et al. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer; 2013. Available at: http://globocan.iarc.fr. Accessed: December 15, 2014.
3.de Martel C, Maucort-Boulch D, Plummer M, Franceschi S. World-wide relative contribution of hepatitis B and C viruses in hepatocellular carcinoma. Hepatology 2015;62:1190–1200
4.Massarweh N N , El-Serag H B . Epidemiology of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma[J]. Cancer Control, 2017, 24(3):107327481772924.
5.Ott JJ, Stevens GA, Groeger J, Wiersma ST. Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity. Vaccine. 2012;30(12):2212–2219.
6.Shiani A , Narayanan S , Pena L , et al. The Role of Diagnosis and Treatment of Underlying Liver Disease for the Prognosis of Primary Liver Cancer[J]. Cancer Control, 2017, 24(3):107327481772924.
7.Llovet JM, Zucman-Rossi J, Pikarsky E, et al. Hepatocellular carcinoma. Nat Rev Dis Primers. 2016;2:16018. Published 2016 Apr 14.
8.Dimitroulis D, Damaskos C, Valsami S, et al. From diagnosis to treatment of hepatocellular carcinoma: An epidemic problem for both developed and developing world. World J Gastroenterol. 2017;23(29):5282-5294.
9.Park JH, Kim JH. Pathologic differential diagnosis of metastatic carcinoma in the liver. Clin Mol Hepatol. 2019;25(1):12-20.
10.Elzouki AN, Elkhider H, Yacout K, Al Muzrakchi A, Al-Thani S, Ismail O. Metastatic hepatocellular carcinoma to parotid glands. Am J Case Rep. 2014;15:343-347.
11.Dargent JL, Deplace J, Schneider E et al: Hepatocellular carcinoma metastatic to the parotid gland: initial diagnosis by fine needle aspiration biopsy. Acta Cytol, 1998; 42(3): 824–26 12.Romanas MM, Cherian R, McGregor DH et al: Hepatocellular carcinoma diagnosed by fine-needle aspiration of the parotid gland. Diagn Cytopathol 2004;30(6): 401–5
13.Vitale AR, Compilato D, Coletti G et al: Metastatic hepatocellular carcinoma of the parotid region without lung metastasis: a case report. Int J Oral Maxillofa Surg, 2009; 38(6): 696–98 14.Moore FR, Bergman S, Geisinger KR: Metastatic hepatocellular carcinoma mimicking acinic cell carcinoma of the parotid gland: a case report. ActaCytol, 2010; 54(5 Suppl.): 889–92
15.Yu YD, Kima DS, Jung SW et al: Metastatic hepatocellular carcinoma to the parotid gland: Case report and review of the literature. Intern J Surg Case Report, 2013; 4(1): 76–80
16.Aiyer HM, Deb S, Rawat G. Metastatic hepatocellular carcinoma to the parotid gland: A diagnostic dilemma with review of the literature. Indian J Pathol Microbiol. 2019;62(4):582-585.
17.Shao YY, Li YS, Hsu HW, et al. Potent Activity of Composite Cyclin Dependent Kinase Inhibition against Hepatocellular Carcinoma. Cancers (Basel). 2019;11(10):1433. Published 2019 Sep 26. doi:10.3390/cancers11101433
18.Yang JD, Hainaut P, Gores GJ, Amadou A, Plymoth A, Roberts LR. A global view of hepatocellular carcinoma: trends, risk, prevention and management. Nat Rev Gastroenterol Hepatol. 2019;16(10):589-604.
19.Shi J, Zhu L, Liu S, Xie WF. A meta-analysis of case-control studies on the combined effect of hepatitis B and C virus infections in causing hepatocellular carcinoma in China. Br J Cancer 2005;92:607–612
20.Omata M, Cheng AL, Kokudo N, et al. Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update. Hepatol Int. 2017;11(4):317-370. doi:10.1007/s12072-017-9799-9
21.Kim TH, Cheung DY, Chung WB et al: A case of metastatic hepatocellular carcinoma of the ovary. Korean J Gastroenterol, 2004; 43(3): 215–18
22.Masci G, Magagnoli M, Grimaldi A et al: Metastasis of hepatocellular carcinoma to the heart: a case report and review of the literature. Tumori, 2004; 90(3): 345–47
23.Yamanishi K, Kishimoto S, Hosokawa Y et al: Cutaneous metastasis from hepatocellular carcinoma resembling granuloma teleangiectaticum. J Dermatol, 1989; 16(6): 500–4
24.Oida Y, Ishii M, Dowaki S et al: Hepatocellular carcinoma with metastasis to the pharynx: report of a case. Tokai J Experimental Clin Medicine, 2005; 30(1): 31–34
25.Font RL, Maturi RK, Small RG, Garcia-Rojas M: Hepatocellular carcinoma metastatic to the orbit. Arch Ophthalmol, 1998; 116(7): 942–45
26.Yasumatsu R, Okura K, Sakiyama Y et al: Metastatic hepatocellular carcinoma of the external auditory canal. World J Gastroenterol, 2007; 13(47): 6436–38
27.Fakhry N, Antonini F, Michel J et al. Fine-needle aspiration cytology in the management of parotid masses: evaluation of 249 patients. Eu Ann Otolaryngol Head Neck Dis 2012;129:131-5. 28. Fakhry N, Santini L, Lagier A, Dessi P, Giovanni A. Fine needle aspiration cytology and frozen section in the diagnosis of malignant parotid tumours. Int J Oral Maxillofac Surg 2014;43:802-5.
29.Singal AG, Pillai A, Tiro J. Early detection, curative treatment, and survival rates for hepatocellular carcinoma surveillance in patients with cirrhosis: a meta-analysis. PLoS Med 2014;11:e1001624.
30.El-Serag HB. Hepatocellular carcinoma. N Engl J Med. 2011 Sep;365(12):1118–27.
31.Llovet JM, Ricci S, Mazzaferro V, Hilgard P, Gane E, Blanc JF, et al.; SHARP Investigators Study Group. Sorafenib in advanced hepatocellular carcinoma. N Engl J Med. 2008 Jul;359(4):378–90.
32.Kudo M, Finn RS, Qin S, Han KH, Ikeda K, Piscaglia F, et al. Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferioritytrial. Lancet. 2018 Mar;391(10126):1163–73.
33.Tian S,Quan H,Xie C,et al. YN968D1 is a novel and selective inhibitor of vascular endothelial growth factor receptor-2 tyrosine kinase with potent activity in vitro and in vivo[J]. Cancer Sci,2011,102( 7) : 1374-1380.
34.Harding JJ, El Dika I, Abou-Alfa GK. Immunotherapy in hepatocellular carcinoma: Primed to make a difference?. Cancer. 2016;122(3):367-377.